Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 60

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States

Hayashi, Paul · 2016 · International Journal of Molecular Sciences

Abstract

Hepatotoxicity due to drugs, herbal or dietary supplements remains largely a clinical diagnosis based on meticulous history taking and exclusion of other causes of liver injury. In 2004, the U.S. Drug-Induced Liver Injury Network (DILIN) was created under the auspices of the U.S. National Institute of Diabetes and Digestive and Kidney Diseases with the aims of establishing a large registry of cases for clinical, epidemiological and mechanistic study. From inception, the DILIN has used an expert opinion process that incorporates consensus amongst three different DILIN hepatologists assigned to each case. It is the most well-established, well-described and vigorous expert opinion process for DILI to date, and yet it is an imperfect standard. This review will discuss the DILIN expert opinion process, its strengths and weaknesses, psychometric performance and future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms17020201

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 28

  1. Hoofnagle, 2004, Drug-induced liver injury network (DILIN), Hepatology, 40, 773, 10.1002/hep.20445 · DOI
  2. Fontana, 2009, Drug-Induced Liver Injury Network (DILIN) prospective study: Rationale, design and conduct, Drug Saf., 32, 55, 10.2165/00002018-200932010-00005 · DOI · Paper page
  3. Agarwal, 2010, Important elements for the diagnosis of drug-induced liver injury, Clin. Gastroenterol. Hepatol., 8, 463, 10.1016/j.cgh.2010.02.008 · DOI
  4. Davern, 2011, Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury, Gastroenterology, 141, 1665, 10.1053/j.gastro.2011.07.051 · DOI · Paper page
  5. Dalton, 2007, The role of hepatitis E virus testing in drug-induced liver injury, Aliment. Pharmacol. Ther., 26, 1429, 10.1111/j.1365-2036.2007.03504.x · DOI · Paper page
  6. Rockey, 2010, Causality assessment in drug-induced liver injury using a structured expert opinion process: Comparison to the Roussel-Uclaf causality assessment method, Hepatology, 51, 2117, 10.1002/hep.23577 · DOI · Paper page
  7. Maria, 1997, Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis, Hepatology, 26, 664, 10.1002/hep.510260319 · DOI · Paper page
  8. Lucena, 2001, Comparison of two clinical scales for causality assessment in hepatotoxicity, Hepatology, 33, 123, 10.1053/jhep.2001.20645 · DOI · Paper page
  9. Arimone, 2005, Agreement of expert judgment in causality assessment of adverse drug reactions, Eur. J. Clin. Pharmacol., 61, 169, 10.1007/s00228-004-0869-2 · DOI
  10. Arimone, 2007, Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions, Br. J. Clin. Pharmacol., 64, 482, 10.1111/j.1365-2125.2007.02937.x · DOI
  11. Hayashi, 2015, Reliability of causality assessment for drug, herbal and dietary supplement hepatotoxicity in the Drug-Induced Liver Injury Network (DILIN), Liver Int., 35, 1623, 10.1111/liv.12540 · DOI · Paper page
  12. Danan, 1993, Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries, J. Clin. Epidemiol., 46, 1323, 10.1016/0895-4356(93)90101-6 · DOI · Paper page
  13. Huang, 2003, Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis, Hepatology, 37, 924, 10.1053/jhep.2003.50144 · DOI · Paper page
  14. Lucena, 2008, Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury, Hepatology, 48, 588, 10.1002/hep.22370 · DOI · Paper page
  15. Ritchie, 2006, Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity, Clin. Infect. Dis., 43, 779, 10.1086/507101 · DOI
  16. Watanabe, 2003, A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus, Clin. Pharmacol. Ther., 73, 435, 10.1016/S0009-9236(03)00014-6 · DOI · Paper page
  17. Donaldson, 2008, Flucloxacillin-induced liver injury: The extended MHC 57.1 haplotype as a major risk factor, Hepatology, 48, 396A
  18. Lucena, 2011, Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles, Gastroenterology, 141, 338, 10.1053/j.gastro.2011.04.001 · DOI · Paper page
  19. Phillips, 2013, Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa, J. Acquir. Immune Defic. Syndr., 62, e55, 10.1097/QAI.0b013e31827ca50f · doi:10.1097/qai.0b013e31827ca50f
  20. Singer, 2010, A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury, Nat. Genet., 42, 711, 10.1038/ng.632 · DOI · Paper page
  21. Spraggs, 2011, HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer, J. Clin. Oncol., 29, 667, 10.1200/JCO.2010.31.3197 · DOI · Paper page
  22. Hirata, 2008, Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: A preliminary case-control study, Pharm. J., 8, 29
  23. Kleiner, 2013, Hepatic histological findings in suspected drug-induced liver injury: Systematic evaluation and clinical associations, Hepatology, 59, 661, 10.1002/hep.26709 · DOI · Paper page
  24. Teschke, 2013, Drug- and herb-induced liver injury in clinical and translational hepatology: Causality assessment methods, quo vadis?, J. Clin. Transl. Hepatol., 1, 59
  25. Navarro, 2014, Hepatotoxicity induced by herbal and dietary supplements, Semin. Liver Dis., 34, 172, 10.1055/s-0034-1375958 · DOI · Paper page
  26. Fleshner, 2005, Evidence for contamination of herbal erectile dysfunction products with phosphodiesterase type 5 inhibitors, J. Urol., 174, 636, 10.1097/01.ju.0000165187.31941.cd · DOI
  27. Saper, 2008, Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet, JAMA, 300, 915, 10.1001/jama.300.8.915 · DOI · Paper page
  28. Rockey, 2015, Liver disorders that can masquerade as drug-induced liver injury, Hepatology, 62, 1149A

Cited by

See all 60

Metadata

Authors
Hayashi, P.
Affiliations
University of North Carolina Liver Center, 8011 Burnett-Womack Building, Chapel Hill, NC 27599-8754, USA
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2016-02-04
Volume
17
Issue
2
Pages
201
ISSN
1422-0067
Cited by
60
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States. https://app.cochat.ai/papers/10.3390/ijms17020201
The paper
Hayashi, P. (2016). Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms17020201

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.